
    
      All patients enrolled into the study will receive standard surgery procedures indicated in
      accordance with medical care standards for the certain disease. Patients after nerve injury
      classified as neurotmesis will receive surgical repair of injured nerves what will be added
      by intraneural injections of pl-vegf165. Safety and efficacy of gene therapy will be assessed
      by physical examination, comprehensive laboratory tests over next 18 month after surgical
      nerve reconstruction.
    
  